Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy

Abstract Data from patients with suspicious lesions on multiparametric magnetic resonance (mpMRI) and a diagnosis of clinically significant prostate cancer (csPCa) who underwent radical prostatectomy (RP) were collected. The aim was to compare csPCa sites identified through whole-mount pathological...

Full description

Bibliographic Details
Published in:	Scientific Reports
Main Authors:	Matteo Pacini, Alessandro Zucchi, Riccardo Morganti, Filippo Dazzi, Antonio Luigi Pastore, Fabio Maria Valenzi, Andrea Fuschi, Yazan al Salhi, Gianluca Giannarini, Vincenzo Ficarra, Alchiede Simonato, Petar Antonov, Pinuccia Faviana, Riccardo Bartoletti
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-02-01
Subjects:	Prostate cancer diagnosis Multiparametric magnetic resonance Targeted fusion prostate biopsy Systematic prostate biopsy Whole mount pathological analysis
Online Access:	https://doi.org/10.1038/s41598-025-88463-w

Similar Items

Role of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy in the Detection of Clinically Significant Prostate Cancer in Patients with Suspicious Digital Rectal Examination
by: Vincenzo Ficarra, et al.
Published: (2024-04-01)

Targeted Prostate Biopsy: How, When, and Why? A Systematic Review
by: Giacomo Rebez, et al.
Published: (2024-08-01)

Diagnostic Value of Cognitive-Registration Multiparametric Magnetic Resonance Guided Biopsy for the Detection of Prostate Cancer after Initial Negative Biopsy
by: Igor Tomašković, et al.
Published: (2018-01-01)

Multivariable Models Incorporating Multiparametric Magnetic Resonance Imaging Efficiently Predict Results of Prostate Biopsy and Reduce Unnecessary Biopsy
by: Shuanbao Yu, et al.
Published: (2020-11-01)

Performance of multiparametric prostate magnetic resonance imaging validated by targeted and systematic transperineal biopsies
by: Richard A. Hsi, et al.
Published: (2023-01-01)

Comparison of Fluoroquinolones and Other Antibiotic Prophylaxis Regimens for Preventing Complications in Patients Undergoing Transrectal Prostate Biopsy
by: Gabriele Tulone, et al.
Published: (2022-03-01)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

The Diagnostic Value of Multiparametric-MRI in Locating Prostate Cancer for Transrectal Ultrasound-Guided Biopsy
by: Sayed Mohammad Sakhaei, et al.
Published: (2024-03-01)

Prostate Biopsy: Is it Still Relevant Today?
by: Ritesh Goel, et al.
Published: (2025-04-01)

Association Between Prostate Cancer Detection Rate and Year of Prostate Biopsy
by: Young Jun Uhm, et al.
Published: (2025-02-01)

Comparison of the Diagnostic Performance of Multiparametric Prostate Magnetic Resonance Imaging Results with Classical Parameters for Prostate Carcinoma in Gray Zone Patients
by: Coşkun Bostancı, et al.
Published: (2024-06-01)

Hematospermia does not increase the risk of prostate cancer detection in prostate biopsy
by: Jae Ryun Park, et al.
Published: (2024-09-01)

A review of transrectal ultrasound guided prostate biopsies: Is there still a role for finger guided prostate biopsies?
by: K.S. Jehle, et al.
Published: (2015-03-01)

MRI to Ultrasound Cognitive Targeted Prostate Biopsy Provides all the Benefit of Ultrasound Fusion Without the Increased Resources
by: Jonathan D. Suderman, et al.
Published: (2023-03-01)

MRI to Ultrasound Cognitive Targeted Prostate Biopsy Provides all the Benefit of Ultrasound Fusion Without the Increased Resources
by: Jonathan D. Suderman, et al.
Published: (2023-03-01)

Does the type of the previous biopsy affect the fusion prostate biopsy results?
by: Gokhan Sonmez, et al.
Published: (2024-09-01)

Routine systematic prostate biopsies not replaced by magnetic resonance imaging-targeted biopsy
by: David Gómez-Ortiz, et al.
Published: (2022-10-01)

Rebiopsy rate after transperineal or transrectal prostate biopsy
by: Jose L. Marenco Jimenez, et al.
Published: (2021-06-01)

3T multiparametric MRI’s accuracy in detecting prostate cancer using Prostate Imaging Reporting and Data System (PIRADS) version 2.1 with prostate biopsy as a reference
by: Mohammad Abdullah Dhulaimi, et al.
Published: (2024-04-01)

MRI-guided biopsies and minimally invasive therapy for prostate cancer
by: Sangeet Ghai, et al.
Published: (2015-01-01)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
by: Pietro Pepe, et al.
Published: (2015-10-01)

Fusion prostate biopsy: tips and tricks to improve rigid registration
by: Angelo Naselli, et al.
Published: (2022-05-01)

Multicentre assessment of transperineal targeted prostate biopsy performed as part of a targeted and systematic biopsy diagnostic strategy in men without previous prostate biopsies
by: Mohammed Sheweita, et al.
Published: (2025-04-01)

Multiparametric MRI and targeted biopsies in the management of prostate cancer patients on active surveillance
by: Kiri eSandler, et al.
Published: (2015-01-01)

COMPARATIVE EVALUATION OF CURRENT METHODS OF ANESTHESIA IN PERFORMANCE OF TRANSRECTAL PROSTATE BIOPSY
by: M. E. Topuzov, et al.
Published: (2015-10-01)

Multiparametric magnetic resonance imaging and magnetic resonance imaging fusion-guided biopsy for the diagnosis of prostate cancer: current status
by: Valentina Testini, et al.
Published: (2024-09-01)

A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies
by: Edoardo Beatrici, et al.
Published: (2024-03-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

Advanced prostate cancer diagnosed by bone metastasis biopsy immediately after initial negative prostate biopsy: a case report and literature review
by: Mingwen Liu, et al.
Published: (2024-05-01)

Clinical study on mpMRI/TRUS software fusion-guided transperineal prostate biopsy
by: Chen Ying, et al.
Published: (2025-01-01)

Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging–targeted Prostate Biopsy: Optimizing the Number of Cores Taken
by: Fabio Zattoni, et al.
Published: (2024-08-01)

Value of cognitive fusion targeted and standard systematic transrectal prostate biopsy for prostate cancer diagnosis
by: Lu-Ping Yu, et al.
Published: (2024-09-01)

Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis
by: Ahmad AE, et al.
Published: (2019-11-01)

Clinical utility of transperineal template-guided mapping prostate biopsy in a selection of patients under active surveillance and confirmation of patients with negative biopsy for prostate cancer
by: Michael Jakun Koo, et al.
Published: (2025-03-01)

Prostate Biopsy: General Consideration and Systematic Biopsy
by: Hyungwoo Ahn
Published: (2023-11-01)

Biparametric vs. Multiparametric MRI in the Detection of Cancer in Transperineal Targeted-Biopsy-Proven Peripheral Prostate Cancer Lesions Classified as PI-RADS Score 3 or 3+1: The Added Value of ADC Quantification
by: Elena Bertelli, et al.
Published: (2024-07-01)

Magnetic resonance imaging–ultrasound fusion-targeted biopsy combined with systematic 12-core ultrasound-guided biopsy improves the detection of clinically significant prostate cancer: Are we ready to abandon the systematic approach?
by: Christopher Antonio Febres-Aldana, et al.
Published: (2020-01-01)

Transrectal ultrasound and needle biopsy of the prostate
by: Tomaž Smrkolj
Published: (2016-01-01)

Impact of Prostate Needle Biopsy on Erectile Function
by: Fatih Yanaral, et al.
Published: (2019-03-01)

Comparison of pain levels in fusion prostate biopsy and standard TRUS-Guided biopsy
by: Abdullah Demirtaş, et al.